Log in to save to my catalogue

In Vivo Molecular Imaging of the Efficacy of Aminopeptidase N (APN/CD13) Receptor Inhibitor Treatmen...

In Vivo Molecular Imaging of the Efficacy of Aminopeptidase N (APN/CD13) Receptor Inhibitor Treatmen...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1155_2021_6642973

In Vivo Molecular Imaging of the Efficacy of Aminopeptidase N (APN/CD13) Receptor Inhibitor Treatment on Experimental Tumors Using 68 Ga-NODAGA-c(NGR) Peptide

About this item

Full title

In Vivo Molecular Imaging of the Efficacy of Aminopeptidase N (APN/CD13) Receptor Inhibitor Treatment on Experimental Tumors Using 68 Ga-NODAGA-c(NGR) Peptide

Publisher

United States

Journal title

BioMed research international, 2021, Vol.2021 (1), p.6642973

Language

English

Formats

Publication information

Publisher

United States

More information

Scope and Contents

Contents

The aminopeptidase N (APN/CD13) receptor plays an important role in the neoangiogenic process and metastatic tumor cell invasion. Clinical and preclinical studies reported that bestatin and actinonin are cytotoxic to APN/CD13-positive tumors and metastases due to their APN/CD13-specific inhibitor properties. Our previous studies have already shown...

Alternative Titles

Full title

In Vivo Molecular Imaging of the Efficacy of Aminopeptidase N (APN/CD13) Receptor Inhibitor Treatment on Experimental Tumors Using 68 Ga-NODAGA-c(NGR) Peptide

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1155_2021_6642973

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1155_2021_6642973

Other Identifiers

ISSN

2314-6133

E-ISSN

2314-6141

DOI

10.1155/2021/6642973

How to access this item